Articles On Probiotec (ASX:PBP)
Title | Source | Codes | Date |
---|---|---|---|
Share Buybacks – Who’s Doing It? 21-8-19
International research suggests shares in companies that buy in their own equities are more likely to respond positively through share price appreciation. Investors should note, however, buying back own stock is not a guarantee of significa... |
FNArena | PBP | 4 years ago |
Share Buybacks – Who’s Doing It?
International research suggests shares in companies that buy in their own equities are more likely to respond positively through share price appreciation. Investors should note, however, buying back own stock is not a guarantee of significa... |
FNArena | PBP | 4 years ago |
Share Buybacks – Who’s Doing It?
International research suggests shares in companies that buy in their own equities are more likely to respond positively through share price appreciation. Investors should note, however, buying back own stock is not a guarantee of significa... |
FNArena | PBP | 4 years ago |
Share Buybacks – Who’s Doing It?
International research suggests shares in companies that buy in their own equities are more likely to respond positively through share price appreciation. Investors should note, however, buying back own stock is not a guarantee of significa... |
FNArena | PBP | 4 years ago |
Share Buybacks – Who’s Doing It?
International research suggests shares in companies that buy in their own equities are more likely to respond positively through share price appreciation. Investors should note, however, buying back own stock is not a guarantee of significa... |
FNArena | PBP | 4 years ago |
Share Buybacks – Who’s Doing It?
International research suggests shares in companies that buy in their own equities are more likely to respond positively through share price appreciation. Investors should note, however, buying back own stock is not a guarantee of significa... |
FNArena | PBP | 4 years ago |
Share Buybacks – Who’s Doing It?
International research suggests shares in companies that buy in their own equities are more likely to respond positively through share price appreciation. Investors should note, however, buying back own stock is not a guarantee of significa... |
FNArena | PBP | 4 years ago |
Share Buybacks – Who’s Doing It?
International research suggests shares in companies that buy in their own equities are more likely to respond positively through share price appreciation. Investors should note, however, buying back own stock is not a guarantee of significa... |
FNArena | PBP | 4 years ago |
Share Buybacks – Who’s Doing It?
International research suggests shares in companies that buy in their own equities are more likely to respond positively through share price appreciation. Investors should note, however, buying back own stock is not a guarantee of significa... |
FNArena | PBP | 4 years ago |
Probiotec acquires leading pharmaceutical packaging business
Pharmaceutical company Probiotec (ASX: PBP) has struck a deal worth at least $23 million to acquire all of the issued shares of pharmaceutical packaging company ABS (Aus) Pty Ltd. In an announcement today, Probiotec said the acquisition wil... |
SmallCaps | PBP | 4 years ago |
Probiotec shares just hit their highest point in nearly a decade
Shares in pharmaceutical drug maker Probiotec (ASX:PBP) have hit their highest point in nearly 10 years, after it acquired a complementary pharmaceutical packaging business. Probiotec told the market this morning that it would pay $23m to a... |
Stockhead | PBP | 4 years ago |
Share Buybacks – Who’s Doing It?
International research suggests shares in companies that buy in their own equities are more likely to respond positively through share price appreciation. Investors should note, however, buying back own stock is not a guarantee of significa... |
FNArena | PBP | 4 years ago |